Ocular Therapeutix (OCUL) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.07% |
| Dec 31, 2025 | -26.44% |
| Sep 30, 2025 | -37.31% |
| Jun 30, 2025 | -35.93% |
| Mar 31, 2025 | -48.67% |
| Dec 31, 2024 | -48.42% |
| Sep 30, 2024 | -45.54% |
| Jun 30, 2024 | -49.40% |
| Mar 31, 2024 | -44.66% |
| Dec 31, 2023 | -29.38% |
| Sep 30, 2023 | -14.22% |
| Jun 30, 2023 | -3.22% |
| Mar 31, 2023 | -4.67% |
| Dec 31, 2022 | -19.75% |
| Sep 30, 2022 | -18.78% |
| Jun 30, 2022 | -15.29% |
| Mar 31, 2022 | -12.59% |
| Dec 31, 2021 | -19.23% |
| Sep 30, 2021 | -18.80% |
| Jun 30, 2021 | -17.99% |
| Mar 31, 2021 | -17.01% |
| Dec 31, 2020 | -16.77% |
| Sep 30, 2020 | 9.07% |
| Jun 30, 2020 | 7.39% |
| Mar 31, 2020 | 6.51% |
| Dec 31, 2019 | 6.16% |
| Sep 30, 2019 | 4.16% |
| Jun 30, 2019 | -25.37% |
| Mar 31, 2019 | -43.00% |
| Dec 31, 2018 | -25.30% |
| Sep 30, 2018 | -21.34% |
| Jun 30, 2018 | -17.82% |